Neural Correlates of Compulsivity

Sponsor
New York State Psychiatric Institute (Other)
Overall Status
Recruiting
CT.gov ID
NCT05195476
Collaborator
International OCD Foundation (Other)
60
1
1
12
5

Study Details

Study Description

Brief Summary

This study aims to collect data from individuals with OCD and healthy controls in order to clarify how learning strategies are employed differently by individuals with compulsive psychopathology and healthy individuals, and how these processes change over time and are related to treatment outcomes. Behavioral and EEG data will be collected during two experimental reinforcement learning tasks from participants diagnosed with OCD (n = 30) and healthy controls (n = 30). Computational modeling, an advanced data analytic approach that can directly link neural measures with behavior, will be used to quantify learning processes. These parameters then will be related to measures of neural events obtained using EEG, a neuroimaging method that has high temporal resolution, to test for evidence of neurocognitive alterations.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Exposure and Response Prevention (Ex/RP)
N/A

Detailed Description

This study will be conducted over the course of eight weeks. First, the participant will meet with the study psychologist to determine eligibility for the study. This includes an assessment of psychiatric and medical history. Eligible participants will then complete an in-person study session which includes completing questionnaires and playing computerized games while an electroencephalogram (EEG) is recorded. Participants will repeat these questionnaires and the EEG task battery eight weeks later. Individuals who have been diagnosed with OCD will receive exposure and response prevention (Ex/RP), the gold-standard behavioral treatment for OCD, during the eight week period.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Participants with OCD will receive exposure and response prevention (Ex/RP), the gold-standard behavioral treatment for OCD. Healthy controls will not receive treatment.Participants with OCD will receive exposure and response prevention (Ex/RP), the gold-standard behavioral treatment for OCD. Healthy controls will not receive treatment.
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Neural Correlates of Compulsivity
Actual Study Start Date :
Dec 17, 2021
Anticipated Primary Completion Date :
Dec 17, 2022
Anticipated Study Completion Date :
Dec 17, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Behavioral Treatment

Participants diagnosed with OCD will receive 16 sessions (1 hour long) of exposure and response prevention (Ex/RP) delivered twice weekly over the course of eight weeks.

Behavioral: Exposure and Response Prevention (Ex/RP)
Ex/RP involves exposure to feared situations, which is expected (and intended for therapeutic benefit) to produce initial moderate anxiety.

Outcome Measures

Primary Outcome Measures

  1. Neural Activity [8 weeks]

    EEG will be recorded while participants complete computerized reinforcement learning tasks at two study sessions conducted eight weeks apart.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 50 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Between 18-50 years of age

  • English-speaking

  • Capacity to provide informed consent

  • Primary diagnosis of OCD with at least moderate severity

Exclusion Criteria:
  • Current or lifetime history of psychiatric disorders other than OCD that may increase the risk of participation

  • History of any significant medical condition that may increase the risk of participation

  • Alcohol or substance use disorder in the past year

  • Exposure and response prevention for OCD within the last six weeks

  • Currently taking psychotropic medication

Contacts and Locations

Locations

Site City State Country Postal Code
1 New York State Psychiatric Institute New York New York United States 10032

Sponsors and Collaborators

  • New York State Psychiatric Institute
  • International OCD Foundation

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Amy Rapp, Postdoctoral Research Fellow, New York State Psychiatric Institute
ClinicalTrials.gov Identifier:
NCT05195476
Other Study ID Numbers:
  • 7867
First Posted:
Jan 19, 2022
Last Update Posted:
Jan 19, 2022
Last Verified:
Jan 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Amy Rapp, Postdoctoral Research Fellow, New York State Psychiatric Institute
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 19, 2022